Matches in Nanopublications for { ?s ?p "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP809152.RAd6aZRJtDzOvxTAXfEyaX3wUhrVnfdj7V86NeWo95TIw130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809152.RAd6aZRJtDzOvxTAXfEyaX3wUhrVnfdj7V86NeWo95TIw130_provenance.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.
- NP809154.RAjM06Q5ATwAlldNm7dodE54aftECnLqXCrHgPpOMKLas130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809154.RAjM06Q5ATwAlldNm7dodE54aftECnLqXCrHgPpOMKLas130_provenance.
- NP809153.RAI0DtaWx9_--Pu9EbjmL1U0X6GSTH5tmzyfWUY1aQ4gU130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809153.RAI0DtaWx9_--Pu9EbjmL1U0X6GSTH5tmzyfWUY1aQ4gU130_provenance.